ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,082Medicare Part D Prescriptions Filled, Including Refills

Rank: 62 out of 393

$544K Total Retail Price of All Prescriptions

Rank: 52 out of 393

336 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

18% of this provider’s 336 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

20% of this provider’s 336 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 6,548 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
RISPERIDONE 328 200 1 75
NAMENDA 323 284 2 59
JANTOVEN 286 201 3 105
AMLODIPINE BESYLATE 242 190 4 4
LEVOTHYROXINE SODIUM 230 185 5 3
METOPROLOL TARTRATE 209 181 6 9
LISINOPRIL 200 156 7 2
QUETIAPINE FUMARATE 198 122 8 104
OMEPRAZOLE 195 154 9 6
HYDROCODONE-ACETAMINOPHEN 187 150 S3 10 5
DONEPEZIL HCL 165 148 11 34
FUROSEMIDE 163 131 12 8
SIMVASTATIN 149 116 13 1
WARFARIN SODIUM 143 120 14 17
GABAPENTIN 138 100 15 15
HEPARIN SODIUM 120 76 16 153
MEROPENEM 111 53 10 17 228
CARVEDILOL 103 73 18 21
NOVOLOG FLEXPEN 99 39 19 127
POTASSIUM CHLORIDE 85 61 20 20
VANCOMYCIN HCL 84 37 21 171
TAMSULOSIN HCL 83 71 22 25
OXYCODONE HCL 82 49 S2 23 36
LEVOFLOXACIN 81 45 24 95
NOVOLIN R 80 58 25 144
ENOXAPARIN SODIUM 77 42 26 183
IPRATROPIUM BROMIDE 77 58 26 106
LANTUS 76 42 28 73
LOVASTATIN 74 54 29 14
RANITIDINE HCL 73 65 30 29
LOXAPINE 72 49 31 255
AMIODARONE HCL 71 56 32 167
SEROQUEL 69 45 33 193
FLUOXETINE HCL 69 47 33 37
CLONIDINE HCL 69 58 33 50
METFORMIN HCL 67 22 36 7
CARBIDOPA-LEVODOPA 66 56 37 142
ALBUTEROL SULFATE 66 48 37 92
GLYBURIDE 65 61 R 39 46
FENTANYL 63 38 S2 40 135
PANTOPRAZOLE SODIUM 62 37 41 56
METRONIDAZOLE 59 44 42 221
LIDODERM 59 59 42 116
OXYCODONE HCL-ACETAMINOPHEN 58 31 S2 44 54
CYMBALTA 58 47 44 88
CITALOPRAM HBR 57 46 46 23
GLIPIZIDE 55 33 47 32
VIMPAT 55 55 47 201
ATORVASTATIN CALCIUM 54 37 49 19
LACTULOSE 54 37 49 148
LEVETIRACETAM 54 36 49 112
HYDRALAZINE HCL 51 43 52 64
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 16, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.